Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jun;5(2):109-14.
doi: 10.1007/s10048-004-0175-2. Epub 2004 Mar 17.

Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16

Affiliations

Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16

Luc Djoussé et al. Neurogenetics. 2004 Jun.

Abstract

Huntington disease (HD) is a neurodegenerative disorder caused by the abnormal expansion of CAG repeats in the HD gene on chromosome 4p16.3. A recent genome scan for genetic modifiers of age at onset of motor symptoms (AO) in HD suggests that one modifier may reside in the region close to the HD gene itself. We used data from 535 HD participants of the New England Huntington cohort and the HD MAPS cohort to assess whether AO was influenced by any of the three markers in the 4p16 region: MSX1 (Drosophila homeo box homologue 1, formerly known as homeo box 7, HOX7), Delta2642 (within the HD coding sequence), and BJ56 ( D4S127). Suggestive evidence for an association was seen between MSX1 alleles and AO, after adjustment for normal CAG repeat, expanded repeat, and their product term (model P value 0.079). Of the variance of AO that was not accounted for by HD and normal CAG repeats, 0.8% could be attributed to the MSX1 genotype. Individuals with MSX1 genotype 3/3 tended to have younger AO. No association was found between Delta2642 (P=0.44) and BJ56 (P=0.73) and AO. This study supports previous studies suggesting that there may be a significant genetic modifier for AO in HD in the 4p16 region. Furthermore, the modifier may be present on both HD and normal chromosomes bearing the 3 allele of the MSX1 marker.

PubMed Disclaimer

References

    1. Huntington G. On chorea. Med Surg Rep. 1872;26:320–321.
    1. Hayden MR, Berkowicz AL, Beighton PH, Yiptong C. Huntington’s chorea on the island of Mauritius. S Afr Med J. 1981;60:1001–1002. - PubMed
    1. Folstein SE. Huntington’s disease: a disorder of families. The Johns Hopkins University Press; Baltimore: 1989.
    1. White RF, Vasterling JJ, Koroshetz W, Myers RH. Neuropsychology of Huntington’s disease. In: White RF, editor. Clinical syndromes in adult neuropsychology: the practioners handbook. Elsevier; New York: 1992. pp. 213–251.
    1. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB. A polymorphic DNA marker genetically linked to Huntington’s disease. Nature. 1983;306:234–238. - PubMed

Publication types